KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) EBT Margin (2016 - 2026)

Medpace Holdings filings provide 12 years of EBT Margin readings, the most recent being 20.89% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 27.0% to 20.89% in Q1 2026 year-over-year; TTM through Mar 2026 was 21.35%, a 97.0% decrease, with the full-year FY2025 number at 21.44%, down 113.0% from a year prior.
  • EBT Margin hit 20.89% in Q1 2026 for Medpace Holdings, down from 22.14% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 24.95% in Q4 2024 to a low of 16.44% in Q2 2023.
  • Median EBT Margin over the past 5 years was 20.89% (2026), compared with a mean of 20.32%.
  • Biggest five-year swings in EBT Margin: plummeted -445bps in 2023 and later skyrocketed 675bps in 2024.
  • Medpace Holdings' EBT Margin stood at 18.69% in 2022, then decreased by -3bps to 18.2% in 2023, then surged by 37bps to 24.95% in 2024, then decreased by -11bps to 22.14% in 2025, then fell by -6bps to 20.89% in 2026.
  • The last three reported values for EBT Margin were 20.89% (Q1 2026), 22.14% (Q4 2025), and 21.64% (Q3 2025) per Business Quant data.